Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 6 | 2012 | 106 | 0.410 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2012 | 39 | 0.360 |
Why?
|
| Gastric Bypass | 1 | 2012 | 69 | 0.350 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 93 | 0.330 |
Why?
|
| New Hampshire | 9 | 2012 | 44 | 0.330 |
Why?
|
| HIV Infections | 2 | 2025 | 976 | 0.280 |
Why?
|
| Mandibular Advancement | 1 | 2007 | 1 | 0.260 |
Why?
|
| Maxilla | 1 | 2007 | 3 | 0.260 |
Why?
|
| Pharynx | 1 | 2007 | 25 | 0.250 |
Why?
|
| Molar, Third | 1 | 2006 | 1 | 0.250 |
Why?
|
| Tooth, Impacted | 1 | 2006 | 1 | 0.250 |
Why?
|
| Tooth Extraction | 1 | 2006 | 2 | 0.250 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2025 | 8 | 0.240 |
Why?
|
| Sutures | 1 | 2006 | 41 | 0.240 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2007 | 61 | 0.240 |
Why?
|
| Incidence | 8 | 2025 | 1383 | 0.240 |
Why?
|
| Lymphoma | 1 | 2025 | 103 | 0.230 |
Why?
|
| Adult | 16 | 2025 | 17116 | 0.190 |
Why?
|
| Neoplasms | 3 | 2025 | 1392 | 0.190 |
Why?
|
| Middle Aged | 15 | 2025 | 17898 | 0.170 |
Why?
|
| Environmental Monitoring | 2 | 2012 | 149 | 0.170 |
Why?
|
| Registries | 3 | 2025 | 885 | 0.170 |
Why?
|
| Occupational Diseases | 2 | 2010 | 267 | 0.140 |
Why?
|
| Melanoma | 2 | 2011 | 331 | 0.140 |
Why?
|
| Male | 14 | 2025 | 30294 | 0.140 |
Why?
|
| Aged | 13 | 2025 | 14648 | 0.140 |
Why?
|
| Female | 15 | 2025 | 33350 | 0.130 |
Why?
|
| Smoking | 3 | 2012 | 861 | 0.130 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 410 | 0.130 |
Why?
|
| Young Adult | 7 | 2025 | 4776 | 0.110 |
Why?
|
| Age Distribution | 2 | 2012 | 258 | 0.110 |
Why?
|
| Adolescent | 7 | 2025 | 6304 | 0.100 |
Why?
|
| Humans | 18 | 2025 | 64238 | 0.100 |
Why?
|
| Occupations | 2 | 2010 | 52 | 0.100 |
Why?
|
| Industry | 2 | 2010 | 60 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 529 | 0.100 |
Why?
|
| Environmental Exposure | 2 | 2011 | 220 | 0.100 |
Why?
|
| Vehicle Emissions | 1 | 2012 | 23 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2012 | 17 | 0.090 |
Why?
|
| Occupational Exposure | 2 | 2012 | 315 | 0.090 |
Why?
|
| Air Pollutants, Occupational | 1 | 2012 | 74 | 0.090 |
Why?
|
| Data Collection | 2 | 2010 | 384 | 0.090 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2012 | 44 | 0.090 |
Why?
|
| Dental Care | 1 | 2011 | 7 | 0.090 |
Why?
|
| Tooth Diseases | 1 | 2011 | 5 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2012 | 1130 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 251 | 0.090 |
Why?
|
| Arsenic | 1 | 2011 | 13 | 0.090 |
Why?
|
| Drinking Water | 1 | 2011 | 21 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 141 | 0.080 |
Why?
|
| Water Pollutants, Chemical | 1 | 2011 | 43 | 0.080 |
Why?
|
| Risk Factors | 3 | 2025 | 5339 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 205 | 0.080 |
Why?
|
| Patient Admission | 1 | 2011 | 198 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 316 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2010 | 221 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2010 | 209 | 0.070 |
Why?
|
| Mammography | 1 | 2010 | 290 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 583 | 0.070 |
Why?
|
| Palate, Soft | 1 | 2007 | 3 | 0.060 |
Why?
|
| Osteotomy, Le Fort | 1 | 2007 | 2 | 0.060 |
Why?
|
| Hyoid Bone | 1 | 2007 | 3 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 5520 | 0.060 |
Why?
|
| Palate, Hard | 1 | 2007 | 4 | 0.060 |
Why?
|
| United States | 4 | 2025 | 7923 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 22 | 0.060 |
Why?
|
| Osteotomy | 1 | 2007 | 20 | 0.060 |
Why?
|
| Maine | 3 | 2011 | 18 | 0.060 |
Why?
|
| Vermont | 3 | 2011 | 16 | 0.060 |
Why?
|
| Polysomnography | 1 | 2007 | 58 | 0.060 |
Why?
|
| Dry Socket | 1 | 2006 | 1 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2010 | 455 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2025 | 53 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 321 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 575 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 288 | 0.050 |
Why?
|
| Mass Screening | 1 | 2010 | 693 | 0.050 |
Why?
|
| Child | 3 | 2025 | 4583 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 1118 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 677 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2012 | 6726 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2478 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1211 | 0.040 |
Why?
|
| New England | 2 | 2012 | 269 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 2018 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2025 | 2604 | 0.040 |
Why?
|
| Sex Factors | 2 | 2011 | 979 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 1569 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2006 | 5691 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 2046 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 3724 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2012 | 27 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 36 | 0.020 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2011 | 2 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 30 | 0.020 |
Why?
|
| Hospitals, Private | 1 | 2011 | 8 | 0.020 |
Why?
|
| Hair Dyes | 1 | 2011 | 5 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 41 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2011 | 17 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 75 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 2011 | 18 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 141 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 31 | 0.020 |
Why?
|
| Gene-Environment Interaction | 1 | 2011 | 51 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2011 | 71 | 0.020 |
Why?
|
| Metallurgy | 1 | 2010 | 16 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 448 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 191 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2012 | 272 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 379 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 135 | 0.020 |
Why?
|
| Mortality | 1 | 2011 | 161 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 67 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 192 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 289 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 138 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 498 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 74 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 99 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 497 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 668 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 198 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 212 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 930 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 759 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1028 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1270 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 1375 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1664 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1681 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2009 | 551 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2737 | 0.010 |
Why?
|